The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
18 pts

Opinion on  Immucor Inc (BLUD)     Sector: Healthcare  >  Industry: Medical Equipment & Supplies
Immucor (BLUD)

Apr 06, 2007 07:23 AM GMT
Robertfreedlandphoto
Return Risk
+1.30% HIGH
Principal

Recent News  

As I reported earlier today, after reviewing my AZZ stock purchase closely (after I hastily purchased some shares) I realized that fiscal year 2008 had been guided lower. The stock is still an interesting selection, but it doesn't really fit my own strategy of looking for stocks with growing revenue and increasing earnings. Especially when the company announces that the upcoming year will be a downturn for its results. I can go down a list of excuses why I missed that story before I purchased the stock, but excuses are excuses and I simply made a mistake.

Looking through the list of top % gainers today, I saw that Immucor (BLUD) a stock that I had previously reviewed almost exactly a year ago, when the stock was trading at $20.51, adjusted for a 3:2 stock split on May 16, 2006, was trading at $33.76, up $2.83 or 9.15% on the day. After reviewing some of the data a little closer (I hope), I decided that this stock made much more sense for me than my AZZ stock, and decided to over-ride my selling rules, and essentially undid my purchase in AZZ and placed Immucor (BLUD) in my trading portfolio. I went ahead and replaced my AZZ with 180 shares of BLUD which I purchased at a price of $33.80.

Let's take a closer look at Immucor and I will show you (and double check!) my findings on this company, explaining why this is a better fit for my own strategy.

IMMUCOR (BLUD) IS RATED A BUY

What exactly does this company do?

According to the Yahoo "Profile" on Immucor , the company

"...and its subsidiaries engage in the development, manufacture, and sale of reagents and automated systems. These are used primarily by hospitals, clinical laboratories, and blood banks in various tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion."

How did they do in the latest quarter reported?

It was the announcement of third quarter 2007 results yesterday after the close of trading that led to the big upward pressure on the stock price today. Revenue for the fiscal third quarter ended February 28, 2007, came in at $57.1 million, up 21% from $47.1 million in the same period last year. Net income came in at $15.0 million, up 28% from $11.7 million during the same period last year. Diluted earnings per share came in at $.21/share up from $.17/share last year.

The company beat expectations of earnings of $.20/share on revenue of $55 million.

These results did not go unnoticed--the Motley Fool commented on these results:

"There were no apparent soft spots in the quarterly earnings release. On a per-share basis, Immucor's earnings increased by 24% over the year-ago quarter, and revenue for the quarter reached $57.1 million for an increase of 21%. Other positive takeaways were that sales of traditional reagent products increased 22% over the prior-year quarter and Immucor's instrument sales increased by 22%.

One thing that never hurts is when you're able to name your own price. And maybe the most notable revelation from management is about the pricing power the company now has. About 82% of the company's revenue increase from the year-ago quarter can be attributed to price increases in the U.S. This pushed the company's gross margin to 70.7%, up from 68.2% in the year-ago quarter."

What about longer-term financial results?

Examining the Morningstar.com "5-Yr Restated" financials on BLUD , we can see a beautiful picture of steadily increasing purple bars on the chart showing the revenue growth with revenue climbing from $84 million in 2002 to $184 million in 2006 and $203 million in the trailing twelve months (TTM).

Earnings were almost as nice, except for a dip from $.21/share in 2003 to $.18/share in 2004, they climbed from $.16/share in 2002 to $.59/share in 2006 and $.75/share in the TTM.

The company has slowly increased its outstanding shares from 55 million in 2002 to 69 million in the TTM. This approximately 25% increase in the float, occurred while revenue was increasing about 150% and earnings were up over 300%. This is a tolerable dilution in the shares from my perspective.

Free cash flow has been positive and fairly steadily growing from $16 million in 2004 to $52 million in 2006. Free cash flow during the TTM has been slightly less at $41 million.

The balance sheet on Morningstar.com appears solid with $75.2 million in cash, which by itself can easily cover both the current liabilities of $25.3 million and the $19.8 million and have approximately $30 million left over! Calculating the 'current ratio', which I consider healthy if at 1.25 or higher, we find a total of current assets of $151.2 million, which when divided by the $25.3 million, yields a current ratio of 5.98, one of the highest current ratios on this blog!

What about some valuation numbers?

Reviewing the Yahoo "Key Statistics" on Immucor , we can see that this is a mid cap stock with a market capitalization of $2.32 billion. The trailing p/e is rich at 47.22, but the forward p/e is better (fye 31-May-08) estimated at 34.10. In spite of the rich p/e, the growth rate is sufficient to bring the PEG ratio (5 yr expected) below 1.0 to 0.92, suggesting a very reasonable valuation based on the anticipated growth in earnings.

Examining the Fidelity.com eresearch website , we can see that the stock is reasonably valued in terms of the Price/Sales (TTM) coming in at 10.39, with an industry average of 28.24. Besides being relatively cheap by this parameter, when examining the profitability of the company as measured by the Return on Equity (ROE), we can see that BLUD comes in at a ROE (TTM) of 33.48%, double the industry average of 16.80%.

Finishing up with Yahoo, we find that the company has 68.83 million shares outstanding with 67.98 million that float. As of 3/12/07, there were 4.83 million shares out short, representing 7.1% of the float or 6.7 trading days of volume. This is even higher than the prior month's short interest of 4.45 million. This short ratio of almost a week and a half of average trading days is well ahead of my own cut-off of 3 days of short interest being significant. With the terrific earnings report yesterday, one can almost hear the panic purchasing of the short-sellers today scrambling to cover their speculative sales. O.K., I am just guessing, but seriously, with all of the great numbers on this company, who would want to be short?

No dividends are reported on Yahoo and the last stock split was the 3:2 split I mentioned earlier which was declared on May 16, 2006.

What does the chart look like?

If we examine the "Point & Figure" chart on Immucor (BLUD) from StockCharts.com , we can see what appears to be a very steady increase in stock price from $1.75/share in March, 2002, to the current level of $33.76, pushing near the high set in January, 2007, when the stock traded as high as $34. The company appears to be trading strongly and I don't see any weakness in this chart from my own amateur perspective.


Summary: What do I think?

Well, I certainly liked what I first read earlier today (and I read it a bit closer than my quick evaluation of AZZ yesterday), and I thought this was too good a match for my blog to not own some shares. It was an easy decision to trade out of my AZZ and into BLUD. I hope it continues to do well.

The earnings report yesterday was solid. Nobody is lowering guidance on this stock! The company beat expectations on both earnings and revenue. And their Morningstar.com report is almost perfect with steady revenue growth, almost perfect earnings growth, a slowly growing number of shares in the face of a rapid improvement in financial numbers, growing and solid free cash flow, and a very strong balance sheet.

On top of this, the Price/Sales is low relative to its group, the Return on Equity is high, and there are loads of shares out short ready to be 'squeezed'. Valuation wise, the earnings are growing so fast that even with the rich p/e, the PEG is still under 1.0. I like this stock a lot. I didn't marry it lol, but I put it in my portfolio.





Update 05/18:


Hello Friends!  Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice!  As always, please remember that I am an amateur investor, so please remember to check with your professional investment advisers prior to making any investment decisions based on information on this website.

I apologize for not reviewing very many stocks the past week.  I have been busy with things at work and at home and wanted to step back a bit for a short time from active posting.  However, I shall continue to keep you posted on activity in my Trading Account and shall try to get some new ideas up on this website soon.  

Earlier today I noticed that my Immucor (BLUD) stock had passed my 8% loss tolerance and I sold out my position of 180 shares at $31.04.  I had purchased these shares just last month on April 5, 2007, at a price of $33.86.  Thus, this represented a loss of $(2.82)/share or (8.3)% since purchase.  My trading rules require me to sell any position, regardless of my own affection for the stock :), or belief in its long-term viability and prospects, if it hits that 8% loss level, and out it went.

Since this is a sale on "bad news", this doesn't give me permission to replace the stock.  Thus, I am back down to 19 positions.  However, my Meridian Bioscience (VIVO) isn't too far from a sale at a gain (?), time will tell on that one, and if so, I shall be able to buy a new position.  But this will again require that one of my remaining 19 positions hits an appreciation target.

Anyhow, I am glad to be blogging this morning, at least for this post.  Hang in there, I shall be back actively blogging shortly!

Thank you so much for visiting and participating in this website.  If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com.

Bob 





Update 09/23:


 

 

 

Hello Friends!  Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice!  As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.

It is the weekend, and that means that it is time to write up a review of my past stock picks.  Last weekend I reviewed the stocks from the week of March 27, 2006.  Moving one week ahead, let's take a look at all of the stock picks from the week of April 3, 2006.  These reviews assume a buy and hold strategy.  In reality, I advocate a disciplined portfolio management strategy that directs me to sell losing stocks quickly and completely and sell gaining stocks slowly and partially at targeted appreciation levels.  I have discussed and shall continue to discuss these techniques throughout my blog.

But for the ease of measurement, let's find out what would have happened if we had indeed purchased equal dollar amount of each stock discussed that week about a year-and-a-half ago.

On April 4, 2006, I posted CheckFree (CKFR) on Stock Picks Bob's Advice when the stock was trading at $54.14.  CKFR closed at $46.82 on September 21, 2007, for a loss of $(7.32) or (13.5)% since posting.

Since CheckFree is to be acquired at $48 in cash on December 31, 2007, subject to regulatory approval,

CHECKFREE (CKFR) IS RATED A HOLD

Looking at the 'point and figure' chart on CheckFree (CKFR) from StockCharts.com, we can see the relatively weak performance of the stock prior to the announcement of the acquisition.

On April 5, 2006, I posted Apple Computer (AAPL) on Stock Picks Bob's Advice when the stock was trading at $67.21.  AAPL closed at $144.15 on September 21, 2007, for a gain of $76.94 or 114.5% since posting.

On July 25, 2007, Apple announced 3rd quarter 2007 results.  Revenue came in at $5.41 billion up from $4.37 billion the prior year same period.  Quarterly profit was $818 million, up sharply from last year's $472 million profit.  On a per share basis this came in at $.92/diluted share up from $.54/share last year.

The company beat expectations of analysts who were expecting earnings of $.72/share on revenue of $5.29 billion.

The "5-Yr Restated" financials on AAPL from Morningstar.com are intact. 

APPLE COMPUTER (AAPL) IS RATED A BUY

Looking at the "point & figure" chart on AAPL from StockCharts.com, we can see a chart that appears phenomenally strong!  

On April 6, 2006, I posted Immucor (BLUD) on Stock Picks Bob's Advice when the stock was trading at $30.76.  BLUD split 3:2 on May 16, 2006, making my effective stock pick price actually $20.51.  BLUD closed at $36.69 on September 21, 2007, giving this stock pick a gain of $16.10 or 78.5% since posting.

On July 25, 2007, Immucor announced 4th quarter 2007 results.  Revenue for the quarter ending May 31, 2007, came in at $61.1 million, up 22% from $50.0 million.  Net income for the quarter was $18.2 million, up 51% from $12.1 million last year.  Diluted earnings came in at $.26/share, up 53% from the $.17/share the prior year.

The Morningstar.com "5-Yr Restated" financials on BLUD are intact.

IMMUCOR (BLUD) IS RATED A BUY

Looking at the "point & figure" chart on BLUD from StockCharts.com, we can see the very strong price movement from as far back as March, 2002.  The stock exhibited some weakness in late 2005, but never 'broke down' below the support lines.

Finally, on April 7, 2006, I posted Aladdin Knowledge Systems (ALDN) on Stock Picks Bob's Advice when the stock was trading at $22.96.  ALDN closed at $20.99 on September 21, 2007, for a loss of $(1.97) or (8.6)% since posting.

On July 19, 2007, Aladdin reported 2nd quarter 2007 results.  For the quarter ended June 30, 2007, revenue came in at $25.5 million, up 22% from $20.9 million the prior year.  Net income came in at $3.9 million or $.26/diluted share, up from $3.3 million or $.22/diluted share the prior year. 

The company beat expectations of revenue of $24.1 million and profit of $24.1 million according to analysts polled by Thomson Financial.  In addition, the company raised guidance for 2007 full year results for a profit of $1.00 to $1.12/share, up from prior guidance of $.90 to $1.09/share.  In addition, they raised expectations on revenue to between $100 million and $106 million, from the prior guidance of $95 million to $102 million.

The Morningstar.com "5-Yr Restated" financials on ALDN are intact.

ALADDIN KNOWLEDGE SYSTEMS (ALDN) IS RATED A BUY

Reviewing the "point & figure" chart on Aladdin from StockCharts.com, we can see that this is a very unimpressive price chart.  The stock has been volatile since June, 2004, when the stock peaked at $27.  The stock dipped as low as $13 in July, 2004, only to see the stock price climb right back to a peak at $32 in November, 2004.  The stock then dipped back to a low of $14 in July, 2006.  The stock appears to be moving higher once again.  This stock chart is certainly not over-extended, however, the volatility is of concern and is the big negative factor for this stock.

 


So how did we do with these stock picks?  In a word phenomenal!  Two stocks showed small losses and two stocks had large gains.  The average performance for these four stocks was a gain of 42.7%!  Certainly past performance is not a reliable indicator for future performance but wasn't that a great week for picking stocks?

Thanks again for stopping by and visiting!  If you have any comments or questions, please feel free to leave them on the blog or email me at bobsadviceforstocks@lycos.com.  If you get a chance, drop by and visit my Stock Picks Podcast Website, or my Covestor Page where my trading portfolio is continually being monitored, or my SocialPicks Page where my blog is reviewed by the people over at SocialPicks!

Regards and wishing you a great week trading!

Bob 





BLUD:  This call was made on 04/06/07 @ $33.91
Rating:   Positive   $33.91 (04/06/07)
Closed:   10/22/2007 @ $36.2 (+6.75% in 199 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
xiao li   N/A     1 point   commented 351 days ago reply

One who gave light into my life. Who made me realize chanel bags that faith along the way is what you need to be contented in everything you do in life. But most of all, the one that gave me light had taught me and molded me of who I am as a person. I learn to sacrifice, and experience to give the chanel bags unconditional love.

Fabric selection can be little complex. One should select the fabric according to the climate, occasion and the wearers own body structure. A right type of fabric canada goose will enhance the look of the person, whereas a wrong selection will work otherwise. Various fabrics such as tulle, organza, satin, lace, chiffon, and taffeta are available, which will give a shining look to the apparel. Embellished with beads, appliqu, and sequins, canada goose jackets the apparels will all the more appealing. The fabric should be selected in a way that it complements with the style canada goose of the apparel. A slim cut dress requires a smooth fabric with flat surface, while chiffon or satin would be good for a costume with layers.

Hong Kong is a prosperous and exiting spot. It canada goose is renowned for the total of investment that it attracts and the company opportunities which it gives you. This, combined with the simple fact that Hong Kong also has an established infrastructure and enjoys wonderful climate for most of the 12 months, makes it an suitable location for a trend week.

The Hong Kong Vogue Week is now into its 18th edition, and with just about every year it grows in popularity and credibility. Every year countless numbers of persons descend on the island to revel in the cacophony of garments which are displayed so elegantly by hundreds of models. The present hermes handbags are now regarded as one of the top style activities in Asia and is an essential pay a visit to for anyone who wishes to make an impression on the style marketplace in this element of the globe or who intends to achieve a supplier from this region.

“National brands retail at a mark up of around moncler jackets three times, which is channelised into branding. We pass this on to the customer while retaining net margins of 8-10%,” says Kailash Gupta, MD of Ahmedabad-based Liverpool Retail India. While national players focus on per-store profitability and saturate metros before targeting tier II and tier III cities, these regional brands bet on scale and dress up smaller cities ed hardy with Westernised brand names.

“We are thrilled to partner with the moncler jackets beautiful Bridget Moynahan,” says Maybelline New York-Garnier President David Greenberg. “Her class, grace and accessibility make her a model representative of the Garnier brand. Most importantly, she exhibits a likeable, healthy beauty that speaks to our consumer mac cosmetics in such a positive way. We are thrilled to announce that we will be working together.”

Moynahan is an all-American girl raised in louis vuitton the East Coast town of Longmeadow, Massachusetts. Before earning international recognition in films and TV, she had a successful modeling career, appearing on the covers of numerous magazines including Glamour, Vogue, Elle and Self. Moynahan has since appeared style shopping in a number of major films, such as Serendipity, The Sum of All Fears, The Recruit, I, Robot, and Lord of War.

“Several regional brands are challenging the online outlet shopping might of big players within the value segment where a significant proportion of Indian demand exists. Many of them will soon grow into national players and capture share from established brands,” says Baqar Naqvi, associate VP retail & consumer goods at Technopak.

The Judy Crowell Collection will feature fashion online shopping mall outerwear and accessories for women seeking to update their wardrobe and help create a polished look. Designed to enhance rather than replace a woman’s wardrobe, the Judy Crowell Collection also caters to women searching for timeless and affordable accessories. Viewers will be surprised and delighted with the newest trends in handbags, sunglasses, scarves and more, along with Ms. Crowell’s advice on where and how to wear each piece.

The City of San Fernando Pampanga Realtors Board , walmart online shopping Inc. (CSFPRB) is holding its three-day 9th Comprehensive Real Estate Seminar and Review (CRESAR) on March 15, 22 & 29, 2009 at the Partyland Restaurant along Dolores in City of San Fernando. The principal lecturer will be led by realtor Atty. Ariel T. Martinez together with a roster of top seminar lecturers and reviewers.

Organized in 2004, CSFRB aims to unite real estate Shop On Line brokers and enable them to effectively conduct their real estate business by adopting such rules and regulations, while maintaining the highest standards of conduct in their transactions, as expressed in the Code of Ethics.

Its main objective is to develop the potential and hone the talent of the aspirants and prepare them to enter the world where they can really display their stuff. Sooner or later, 2011 fashion style these models would land slots in TV commercials, billboard and print ads, fashion shows and luckily, showbusiness.

The plus size of women start around 14W.Some really Fashion exotic clothes is produced for plus size women.More and more categories.

Plus size clothing is not for hiding you body.If gift shops you choose right fitting clothes it will make you feel more sensuous.No doubt, modern plus size clothing will put you on a par with mainstream fashion.With a nice knee length skirt or dress you can show your legs.Low cut tops and a lot more are available in plus sizes.

The T-shirt,summer time paddock boots and a lightweight mac cosmetics pair of breeches that had been staples to your clothes in the summer just won’t cut it when you are preparation your mount in mbt shoes cold weather. With all the modern fabric systems, females horse using winterwear has evolved from colossal coats that riders had to don and tangle with in the past. There are many options obtainable in females horse riding winterwear that will mbt shoes getting you feeling comfortable, riding effectively, andlooking your very best.

If I were ask to describe each person I’ve met in my life, I can honestly say that NO one had ever made a negative impact on me, they left me with a positive impact on mbt shoes life. I always find a good reason what I’ve learn with them.

To find you dream wedding gown you do not have to search long anymore.Do not worry that you do not find a wedding gown easily.You can choose a perfect bridal gown among thousands of bridal dresses in a plus size department store.

Will Keira Knightley wow us with another sunglass celluloid fashion moment when she plays F Scott Fitzgerald’s infamous wife, Zelda, in the biopic, The Beautiful and the Damned? She can pick up tips on goddess dressing at New York’s Costume Institute, which will investigate screen-siren style as part of its American sunglasses Women exhibition in May.

Glastonbury will celebrate its 40th anniversary handbag this year, with U2 confirmed as a headline act. Fashion is already ahead of the game: Chloé has rainproof ponchos, and Hunter wellies are now handbags website being sold at boutiques such as Browns. It’s also selling waterproof eco-parkas made from recycled handbags materials by Royal College of Art graduate, Christopher Raeburn.

In 2005, retracting her statement about louis vuitton not getting out of bed for less than $10,000 a day.] I can’t stand the way this follows me around. I said it a long time ago, and I hope today louis vuitton I am a different person. Now I get out of bed for a much better reason. I’m part of a team that christian louboutin raises millions of dollars and raises awareness of HIV and AIDS all over the world.

“Learn to live on what you have, whether it be a dollar in your pocket, or alone by yourself. Make the best out of it, and only then you can say you lived your life. Self christian louboutin contentment and self-realization is what you need chanel bags shop in order to appreciate what life has to offer”.

There are a lot of people who became a part of your hermes bag. There’s mom and dad, brother s or sisters, aunt and uncle, your bestfriend, or that special someone. But, do you ever stop shopping shops and realize what is it that you learn from them? I learn a lot from people and I haven’t had the chance to thank each one of them individually. But I do hope that they know that I am very thankful for being a part of my life.

Practically all designers used grey christian louboutin online , sand colors and strict cuts in order to create noble and restrained style. Filipe Fahsca’s collection was not the exception. He chose desert and its shades as the most inspiring topic of his collection. The style reminded me a sophisticated metaphor of ed hardy a city atmosphere with busy and beautiful women on its streets. Still, the designer did not forget about women’s passions, which influenced the choice of materials and cuts: silk and viscose jerseys, crepe georgette, and silk mousseline; feminine chanel bags silhouette with fluid skirts of all lengths.

“We don’t wake up for less hermes bags than $10,000 a day.” (Spoken in Vogue in 1990 to Jonathan Van Meter, talking about money and how she and a few other models were calling the shots and changing the game.)


I don’t diet. I just don’t eat as much as tiffanys jewelry I’d like to.

However , you can now be updated with the hermes bag most recent trends and be the coolest fashionista in the town. You can actually do this without waiting for another issue of a favourite fashion mag. This is as New Designer Fashion is available for all style experts in the world to permit you to start your holidays being tiffany jewelry fashionable, the whole year thru.

As the name itself implies, New Designer moncler jackets Fashion is a fashion blog showcasing the recent trends and styles in the fashion industry. Except for that, we not only cover celebrity moncler jackets trends but also the classic fashion and staples style sunglasses of fashion. Everything that has to do with fashion will be touched on.

Life is too precious and time is too short. So style sunglasses don’t make it miserable because things didn’t work out in your life. There are only two things you can do to make Life worth it. One is to make the best out of it and two is to live and learn from it. From my life learning experience, I truly believe that at the age of 24 that I have become a better person now because of people that have left very good footprints in my life. I had experience the good and the worst situation ever and yet I feel blessed and thankful for everything.

Designers like Michael Kors adorned their models mac cosmetics in slinky, draped gowns, typically cinching them at the waist or over the hip, and letting them movement gracefully tiffany jewelry down, subtly revealing every woman’s purely natural shape.


Weirdly adequate, but yet another sensational Fall/Winter months look for the 2011 year is the pajama/jumpsuit trend. Style houses like Max Azria and Acne sent designs ed hardy clothing down the runway in denim, leather, velvet and khaki jumpsuit type get-ups that look just about like they have been modeled after a plumber’s get the job done uniform. The Acne collection even featured a product in a pair of plastic-shiny leather, gold, metallic general capri pants.


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Immucor Inc (BLUD)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
80.0%
Top:
100.0%




Latest Picks by Robert Freedland
Symbol SP Sentiment Rating Return Since
RMD Positive -49.52% 04/05/10
VIVO Positive -5.17% 04/05/10
MORN Positive +18.53% 04/05/10
GHM Positive +0.16% 04/05/10
JCI Neutral/Hold -1.17% 09/04/08

View All >
   
Robert Freedland previously rated BLUD
Positive n/a Immucor (BLUD)
04/03/2008
7
Neutral/Hold -28.70% Immucor (BLUD)
10/22/2007
6





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch